Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Cash Flow
HK:9989's free cash flow for Q1 2025 was ¥503.02M. For the 2025 fiscal year, HK:9989's free cash flow was decreased by ¥1.99B and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Cash Flow
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Operating Cash Flow
¥ 2.19B
¥ 398.22M
-
-
¥ 37.28M
Investing Cash Flow
-
¥ 1.22B
¥ 249.84M
¥ 719.93M
-
Financing Cash Flow
-
-
¥ 329.56M
-
¥ 2.51B
End Cash Position
¥ 1.42B
¥ 1.77B
¥ 1.32B
¥ 1.48B
¥ 1.33B
Free Cash Flow
¥ 1.99B
-
-
-
-
Currency in CNY
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Cash Flow